These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 8262547
1. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Väkevä A, Laurila P, Meri S. Immunology; 1993 Oct; 80(2):177-82. PubMed ID: 8262547 [Abstract] [Full Text] [Related]
2. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Väkevä A, Laurila P, Meri S. Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272 [Abstract] [Full Text] [Related]
3. Regulation of complement membrane attack complex formation in myocardial infarction. Väkevä A, Laurila P, Meri S. Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345 [Abstract] [Full Text] [Related]
4. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. Schäfer H, Mathey D, Hugo F, Bhakdi S. J Immunol; 1986 Sep 15; 137(6):1945-9. PubMed ID: 3528291 [Abstract] [Full Text] [Related]
5. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Väkevä A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. Am J Pathol; 1994 Jun 15; 144(6):1357-68. PubMed ID: 7515561 [Abstract] [Full Text] [Related]
6. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas. Vlaicu R, Rus HG, Niculescu F. Med Interne; 1988 Jun 15; 26(1):21-7. PubMed ID: 3399815 [Abstract] [Full Text] [Related]
7. Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium. Oliveira GH, Brann CN, Becker K, Thohan V, Koerner MM, Loebe M, Noon GP, Torre-Amione G. Am J Cardiol; 2006 Jun 01; 97(11):1626-9. PubMed ID: 16728227 [Abstract] [Full Text] [Related]
8. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction. Tada T, Okada H, Okada N, Tateyama H, Suzuki H, Takahashi Y, Eimoto T. Virchows Arch; 1997 Apr 01; 430(4):327-32. PubMed ID: 9134044 [Abstract] [Full Text] [Related]
9. A reexamination of the role of clusterin as a complement regulator. Hochgrebe TT, Humphreys D, Wilson MR, Easterbrook-Smith SB. Exp Cell Res; 1999 May 25; 249(1):13-21. PubMed ID: 10328949 [Abstract] [Full Text] [Related]
10. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin. French LE, Polla LL, Tschopp J, Schifferli JA. J Invest Dermatol; 1992 May 25; 98(5):758-63. PubMed ID: 1569324 [Abstract] [Full Text] [Related]
11. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Nijmeijer R, Krijnen PA, Assink J, Klaarenbeek MA, Lagrand WK, Veerhuis R, Visser CA, Meijer CJ, Niessen HW, Hack CE. Eur J Clin Invest; 2004 Dec 25; 34(12):803-10. PubMed ID: 15606722 [Abstract] [Full Text] [Related]
12. Intravenous clusterin administration reduces myocardial infarct size in rats. Van Dijk A, Vermond RA, Krijnen PA, Juffermans LJ, Hahn NE, Makker SP, Aarden LA, Hack E, Spreeuwenberg M, van Rossum BC, Meischl C, Paulus WJ, Van Milligen FJ, Niessen HW. Eur J Clin Invest; 2010 Oct 25; 40(10):893-902. PubMed ID: 20854280 [Abstract] [Full Text] [Related]
13. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. French LE, Tschopp J, Schifferli JA. Clin Exp Immunol; 1992 Jun 25; 88(3):389-93. PubMed ID: 1606720 [Abstract] [Full Text] [Related]
14. Temporal induction of clusterin in the peri-infarct zone after experimental myocardial infarction in the rat. Silkensen JR, Hirsch AT, Lunzer MM, Chmielewski D, Manivel JC, Muellerleile MR, Rosenberg ME. J Lab Clin Med; 1998 Jan 25; 131(1):28-35. PubMed ID: 9452124 [Abstract] [Full Text] [Related]
15. Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. Haahr-Pedersen S, Bjerre M, Flyvbjerg A, Mogelvang R, Dominquez H, Hansen TK, Galatius S, Bech J, Madsen JK, Søgaard P, Jensen JS. J Invasive Cardiol; 2009 Jan 25; 21(1):13-9. PubMed ID: 19126922 [Abstract] [Full Text] [Related]
16. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. Kilgore KS, Park JL, Tanhehco EJ, Booth EA, Marks RM, Lucchesi BR. J Mol Cell Cardiol; 1998 Jan 25; 30(1):75-85. PubMed ID: 9500866 [Abstract] [Full Text] [Related]
17. Evaluation of the membrane attack complex of complement for the detection of a recent myocardial infarction in man. Robert-Offerman SR, Leers MP, van Suylen RJ, Nap M, Daemen MJ, Theunissen PH. J Pathol; 2000 May 25; 191(1):48-53. PubMed ID: 10767718 [Abstract] [Full Text] [Related]
18. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC). Chauhan AK, Moore TL. Clin Exp Immunol; 2006 Sep 25; 145(3):398-406. PubMed ID: 16907906 [Abstract] [Full Text] [Related]
19. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Freixes M, Puig B, Rodríguez A, Torrejón-Escribano B, Blanco R, Ferrer I. Acta Neuropathol; 2004 Oct 25; 108(4):295-301. PubMed ID: 15235804 [Abstract] [Full Text] [Related]
20. The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. Kilgore KS, Naylor KB, Tanhehco EJ, Park JL, Booth EA, Washington RA, Lucchesi BR. J Pharmacol Exp Ther; 1998 Jun 25; 285(3):987-94. PubMed ID: 9618399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]